Indiana University School of Medicine researchers have identified multiple species of bacteria that, when present in the gut, are linked to an increased risk of developing severe malaria in humans and mice.
Risk Adjusted Net Present Value: What is the current valuation of Celltrion’s Aflibercept Biosimilar.
Share this article The revenue for Aflibercept Biosimilar. is expected to reach an annual total of $233 mn by 2039 globally based off GlobalData’s Revenue